Skip to content
healthcare.dev

Cathflo Activase

NDC 50242-041, Alteplase, injection, powder, lyophilized, for solution, from Genentech, Inc..

Product NDC
50242-041
Status
Listed
Labeler
Genentech, Inc.
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA103172
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50242-041 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ALTEPLASE2.2 mg/2mL
Package NDCNDC-11Package
50242-041-105024200411010 VIAL in 1 CARTON (50242-041-10) / 2 mL in 1 VIAL
50242-041-64502420041641 VIAL in 1 CARTON (50242-041-64) / 2 mL in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/91ecdef2-95ff-42dd-a31c-c8a09cab3ad9
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=50242-041
  • NADAC price for package 50242004164

    GET /v1/drugs/nadac/50242004164

Use it

Look up 50242-041 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50242-041 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50242-041. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.